Google Inc. (GOOG) Message Board

love it

This can be a good play for long term .Market will rivese at 3:30PM

expect huge gap up on takeover in three months-cash rich co

FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face

IRVINE, Calif.--(BUSINESS WIRE)-- Allergan, Inc., (NYSE: AGN) is pleased that the U.S. Food and Drug Administration (FDA) General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee has voted unanimously that the benefits of JUVÉDERM VOLUMA™ XC, an injectable hyaluronic acid dermal filler for cheek augmentation to correct age-related volume deficit in the mid-face, outweigh the risks. If approved, JUVÉDERM VOLUMA™ XC would be the first and only dermal filler in the United States with this indication.
"Today's recommendation is an important step in the FDA review process for JUVÉDERM VOLUMA™ XC," said Scott M. Whitcup M.D., Executive Vice President, Research and Development, Chief Scientific Officer, Allergan. "Allergan is committed to working with the FDA as they continue their review of our PMA for JUVÉDERM VOLUMA™ XC, with the goal of providing consumers with the first treatment option that has been specifically developed to help restore cheek volume that has been lost over time."
The Advisory Committee's recommendation, although not binding, will be considered by the FDA when making the final approval decision for JUVÉDERM VOLUMA™ XC. If approved by the FDA, Allergan anticipates launching JUVÉDERM VOLUMA™ XC in late 2013.

run by money managers .Now they are buying in 401k plan

1,Buy OC warrants B target 100% upside
2.Buy INFN 100 % upside
3. Buy ESI 100% upside

mousse in Hair stage 5 we need to cut his hair

I am very serious -this guy we need to get -you know I am talking about KIM small Tiny guy in north Korea wear the woolen coats and nice shoes

NUKE missile may kill at least 10 m People in USA